Robert Burgess, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 |
Jay W. White, DO Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 Fax: 605-721-8458 |
Dallin N Christensen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 241 Minnesota St, Rapid City, SD 57701 Phone: 605-791-0602 |
Robert Ferrell, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 |
Troy Benjamin Howard, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 |
Vaughan Richard Bowen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4447 S Canyon Rd Ste 6, Rapid City, SD 57702 Phone: 605-716-0548 Fax: 605-716-0447 |
Jack Robert Schleiffarth, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4940 5th St Ste 2b, Rapid City, SD 57701 Phone: 605-791-0602 Fax: 605-791-0978 |
Mr. Dale Eugene Gunderson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 504 E Monroe St, Rapid City, SD 57701 Phone: 605-394-6761 |
Mary Snyder, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3615 5th St, Suite 101, Rapid City, SD 57701 Phone: 605-343-7208 Fax: 605-343-7132 |
Ronald Mark Guy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4141 5th St, Rapid City, SD 57701 Phone: 605-791-0602 Fax: 605-791-0978 |
Dr. Gary L Carlson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2805 5th St, Suite 100, Rapid City, SD 57701 Phone: 605-719-5700 Fax: 605-719-5701 |
News Archive
Prospect Medical Holdings, Inc., today announced the completion of its exchange offer (the "Exchange Offer") for any and all of its outstanding 123/4% Senior Secured Notes, Series A, due 2014, which are not registered under the Securities Act of 1933 (the "Private Notes"), for an equal principal amount of its 123/4% Senior Secured Notes, Series B, due 2014, which have been registered under the Securities Act of 1933.
Applied Spectral Imaging (ASI) announced today that ASI's GenASIs Scan & Analysis, SpotScan used for the detection of chromosomal aberrations in bladder cancer has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
Research led by scientists at the University of California, San Diego (UCSD) School of Medicine has identified a target with potential as an effective new therapy for chronic spasticity and rigidity, a painful condition that often results from spinal cord injury.
› Verified 2 days ago